Paul Hickey, President & CEO of ReShape Lifesciences RSLS, was recently a guest on Benzinga's All-Access.
ReShape is a physician-led weight-loss and metabolic health solutions company. It offers an integrated portfolio of proven products and services that help manage and treat obesity and metabolic diseases.
The company's premiere product, the FDA-approved Lap-Band, provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy.
The company received approval from the FDA for a PMA supplement for a new Lap-Band 2.0, an important leap forward in the technology.
Watch the interview here:
Featured photo by Emma Simpson on Unsplash.
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.